164 related articles for article (PubMed ID: 7451917)
1. [First trimester termination of pregnancy. The value of treating the cervix pre-operatively in the primigravid patient by extra-amniotic administration of a single dose of F2-alpha prostaglandin gel (author's transl)].
De Grandi P; Nguyen TH; Kunz B; Suppan P
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(5):587-94. PubMed ID: 7451917
[TBL] [Abstract][Full Text] [Related]
2. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
Schmidt W; Widmaier G; Ditz S; Kubli F
Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
[TBL] [Abstract][Full Text] [Related]
3. [Prostaglandin F-2-alpha gel for induction of midtrimester abortion (author's transl)].
De Grandi P; Nguyen The H; Suppan P; Kunz B
J Gynecol Obstet Biol Reprod (Paris); 1979; 8(5):455-62. PubMed ID: 541483
[TBL] [Abstract][Full Text] [Related]
4. [The effects and side-effects of the intra-cervical application of prostaglandin F-2 alpha during early pregnancy (author's transl)].
Sievers S; Hiltmann WD; Wiest W; Liebenstein J
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):800-4. PubMed ID: 700342
[TBL] [Abstract][Full Text] [Related]
5. [Use of prostaglandin F2 alpha gel prior to termination of pregnancy of primigravidae for cervix maturation (author's transl)].
Köhler G; Göretzlehner G; Lober R
Zentralbl Gynakol; 1981; 103(14):818-22. PubMed ID: 6945784
[TBL] [Abstract][Full Text] [Related]
6. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
Rath W; Ulbrich R; Kuhn W
Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953
[TBL] [Abstract][Full Text] [Related]
7. Experiences with a new priming score for estimation of efficiency of PGF2 alpha-gel for cervical maturation in first trimester induced abortion.
Göretzlehner G; Köhler G; Schuchart A; Nikschick S
Acta Chir Hung; 1986; 27(3):131-6. PubMed ID: 3469839
[TBL] [Abstract][Full Text] [Related]
8. Two different methods of prostaglandin administration for cervix priming before interruption of the first trimester pregnancy.
Veszprémi B; Halvax L; Csaba IF
Acta Chir Hung; 1987; 28(1):27-30. PubMed ID: 3473856
[TBL] [Abstract][Full Text] [Related]
9. [Local application of prostaglandin F2 alpha to primigravid interruption patients in first trimester].
Heinz M; Günther H; Pundrich C
Zentralbl Gynakol; 1982; 104(13):784-90. PubMed ID: 6958145
[TBL] [Abstract][Full Text] [Related]
10. [Cervical dilatation using PGF2 alpha gel before voluntary interruption of pregnancy during the first trimester].
Maria B; Maghioracos P; Stragietti A; Prugnaud JL
J Gynecol Obstet Biol Reprod (Paris); 1983; 12(7):789-94. PubMed ID: 6668409
[TBL] [Abstract][Full Text] [Related]
11. [Priming of the cervix with prostaglandins in the first and second trimester].
Brabec W
Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
[TBL] [Abstract][Full Text] [Related]
12. Effect of enzaprost F on the dilatation of cervical canal following intracervical and extra-ovular application in the first trimester of pregnancy.
Pajor A; Matányi S; Lintner F; Soltész K; Siklós P; Hintalan A
Ther Hung; 1985; 33(4):193-7. PubMed ID: 3870230
[TBL] [Abstract][Full Text] [Related]
13. [Priming of the cervix at term with 3 methods: the oxytocin infusion, the administration of prostaglandin F2 alpha gel and the administration of prostaglandin E2 gel into the cervical canal (author's transl)].
Schmidt W; Widmaier G; Arabin B; Ditz S; Kubli F
Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):6-10. PubMed ID: 6916666
[No Abstract] [Full Text] [Related]
14. [Intracervical application of prostaglandin F2 alpha gel as low risk method of cervical dilatation for therapeutic abortion (author's transl)].
Fritzsche H; Seewald HJ; Voigt R
Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):237-8. PubMed ID: 7215769
[TBL] [Abstract][Full Text] [Related]
15. [Methods of artificial termination of pregnancy with special consideration of the use of prostaglandin (author's transl)].
Kepp R
Geburtshilfe Frauenheilkd; 1976 Sep; 36(9):700-5. PubMed ID: 976713
[TBL] [Abstract][Full Text] [Related]
16. [Preventing complications due to dilatation by intracervical application of a prostaglandin-gel (author's transl)].
Kühnie H; Grande P; Kuhn W
Geburtshilfe Frauenheilkd; 1977 Aug; 37(8):675-80. PubMed ID: 902962
[TBL] [Abstract][Full Text] [Related]
17. [Early complications after intra-cervical application of prostaglandin F2 alpha gel for therapeutic abortion (author's transl)].
Hölzel D; Berle P
Geburtshilfe Frauenheilkd; 1981 Jun; 41(6):421-3. PubMed ID: 6910456
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with sulprostone (author's transl)].
Brabec W; Dapunt O; Bichler A
Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
[TBL] [Abstract][Full Text] [Related]
19. The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae.
Wang YF; Jin YC; Wu YE; Gu LJ; Xie XH
Chin Med J (Engl); 1989 Mar; 102(3):200-2. PubMed ID: 2503307
[TBL] [Abstract][Full Text] [Related]
20. [Cervical complications in the use of prostaglandin F2alpha (PGF2alpha) in pregnancy].
Seifert B; Woraschk HJ
Zentralbl Gynakol; 1983; 105(4):208-11. PubMed ID: 6573824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
